TRIB
$1.42
Trinity Bio ADR
$.03
2.16%
TRIB
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Nov 19
9:05 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when TRIB reports earnings?
Beat
Meet
Miss

Where is TRIB's stock price going from here?
Up
Flat
Down
Stock chart of TRIB
Analysts
Summary of analysts' recommendations for TRIB
Score
Grade
Pivots
Resistance
$1.61
$1.53
$1.46

$1.38

Support
$1.31
$1.23
$1.16
Tweet
Growth
Description
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Peers
ImmunomedicsMyriad GeneticsQuidelCareDxMeridian BioscienceSurModics